Palmitic Acid methyl ester is a 17 carbon saturated fatty acid ester. This agent has also been reported to cause autolysis of membranous structures, especially mitochondria. Studies on rat superior cervical ganglion (SCG) suggest that Palmitic Acid methyl ester is released from SCG and induces significant aortic dilation. Furthermore, this compound displays the ability to inhibit phagocytic activity and NO production of certain cells. Additionally, Palmitic Acid methyl ester appears to reduce levels of TNFα, PGE2, and IL-10 without affecting ATP levels. Palmitic Acid methyl ester is an inhibitor of NF κ B.
1. Cai, P., et al. 2005. Toxicology. 210: 197-204. PMID: 15840433
2. Sarkar, S., et al. 2006. J. Biochem. Mol. Toxicol. 20: 302-308. PMID: 17163484
3. Lin, H.W., et al. 2008. Proc. Natl. Acad. Sci. U.S.A. 105: 19526-19531. PMID: 19057014
4. Wang, Y.N., et al. 2010. J. Econ. Entomol. 103: 1372-1377. PMID: 20857750
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.